ArticleTranslational gastroenterology and hepatology2025
Endoscopic treatment and outcome-oriented classification of biliary strictures after liver transplantation: a multicenter retrospective cohort study.
Article in Translational gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To date, there is no consensus classification of post-liver transplantation biliary strictures (LTBS), particularly for guiding treatment. This study aimed to propose a novel classification system for guiding treatment choice and prognosis prediction. Methods: Patients with biliary stricture (BS) from three centers were analyzed retrospectively. Combined with the latest guidelines, a location-based classification system was developed that included the following categories: extrahepatic BS (type I), perihilar BS (type II), and intrahepatic BS (type III). Stent treatment choices were assessed, and a fully covered self-expandable metal stent (FCMS) with plastic biliary stent (PBS) implantation method for type II was introduced. Treatment characteristics and outcomes among the three types were also analyzed. Results: According to initial successful endoscopic cholangiography, 96 patients were classified into three types: I (43.8%), II (32.3%) and III (24.0%). For type I patients, fewer treatment sessions (P=0.02) and lower costs (P=0.04) were noted for FCMS compared to PBS. Compared to PBS implantation alone, FCMS + PBS had a similar advantage as the type II group. During the follow-up period, 69.0% of type I, 61.3% of type II and 34.7% of type III patients achieved stent-free success, and type III patients demonstrated the worst treatment effects (P=0.03). The stent duration, number of endoscopic procedures increased from type I to type III patients (P=0.04). Conclusions: This location-based classification provides insights for clinical treatment recommendations, offering a typological basis for establishing a standardized treatment protocol for BS after liver transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.